[
  {
    "ts": null,
    "headline": "Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda",
    "summary": "The Global Multiple Myeloma Market is projected to grow from USD 21.78 billion in 2024 to USD 40.41 billion by 2033, at a CAGR of 7.11%. Growth drivers include rising multiple myeloma cases, advances in targeted therapies like monoclonal antibodies, and the increasing adoption of immunotherapies. Enhanced diagnostics and greater healthcare accessibility are boosting market expansion. Key regions such as the U.S., Europe, and Asia-Pacific, are witnessing heightened therapy adoption. Challenges in",
    "url": "https://finnhub.io/api/news?id=935f341a4411b701496e42970e26df9cbaf2110b44122724cea5bef64808ce44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754996340,
      "headline": "Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda",
      "id": 136315997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "The Global Multiple Myeloma Market is projected to grow from USD 21.78 billion in 2024 to USD 40.41 billion by 2033, at a CAGR of 7.11%. Growth drivers include rising multiple myeloma cases, advances in targeted therapies like monoclonal antibodies, and the increasing adoption of immunotherapies. Enhanced diagnostics and greater healthcare accessibility are boosting market expansion. Key regions such as the U.S., Europe, and Asia-Pacific, are witnessing heightened therapy adoption. Challenges in",
      "url": "https://finnhub.io/api/news?id=935f341a4411b701496e42970e26df9cbaf2110b44122724cea5bef64808ce44"
    }
  },
  {
    "ts": null,
    "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
    "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
    "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754988120,
      "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
      "id": 136316075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
      "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3"
    }
  }
]